NetworkNewsBreaks – GivBux Inc. (GBUX) Signs LOI
Post# of 10
GivBux (OTC: GBUX), a Super App and charitable giving platform, has signed a Letter of Intent to acquire VitorganAmerica.shop, a distributor of biomolecular health products, for $39 million. The acquisition aims to integrate Vitorgan’s regenerative supplements into GivBux’s expanding distribution network across the U.S. and Latin America. Led by Dr. David Contreras, VitorganAmerica.shop produces FDA-registered biomolecular therapies designed for cellular regeneration. GivBux President Umesh Tim Singh stated the deal strengthens the company’s product portfolio and direct-to-consumer reach. The acquisition’s terms will be finalized in a forthcoming Definitive Agreement.
NOTE TO INVESTORS: The latest news and updates relating to GBUX are available in the company’s newsroom at https://nnw.fm/GBUX
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer